… Acinetobacter baumannii has emerged as an important nosocomial pathogen … vitro
studies found that colistin and meropenem combination therapy could exert synergistic effects…

… baumannii clinical isolates. With the exception of polymyxins … 9-t-butylglycylamido derivative
of minocycline) remain as the major … In vitro activity of tigecycline and colistin against clinical …

… of the in vitro synergistic effect of antimicrobials against XDR … in-vitro activity of antimicrobial
combinations against colistin-… /sulbactam, carbapenems, minocycline, tigecycline, rifampicin …

… treated with a combination of three antibiotics—colistin, rifampicin, and … baumannii clinical
isolates. Interestingly, all of the 8 CRT … of imipenem-resistant Acinetobacter baumannii clones …

… clinical isolates tested under sub-minimal inhibitory concentrations. Then, we observed
synergistic effects (in 22%, 56% and 11% of the isolates) … ), polymyxins (colistin or polymyxin B) …

… Hv-CRAB-BSI showed lower resistance to minocycline than non-hv-… combinations, revealing
that although synergism was rarely observed, the combination of colistin and minocycline …

… , β lactam/β-lactamase inhibitor combinations, and fluoroquinolones. A wound … colistin
therapy. The seventh patient received imipenem for 6 weeks but relapsed with imipenem-resistant …

… can use minocycline as an alternative to colistin in most multi-drugresistant Acinetobacter
cases. … As a result, either as a single drug or in combination with other drugs it is very effective …

… in vitro, in vivo, and clinical studies that evaluate combinations that … , Klebsiella pneumoniae,
Acinetobacter baumannii, or … , the combination of minocycline and colistin was synergistic …

… the ribosomes than tetracycline and minocycline. It is likely that … In the present study, 78.6%
of imipenem-resistant isolates … among clinical isolates of Acinetobacter in the UK, and in vitro …